Objectives: This study investigated the cost effectiveness of early cardiac resynchronization
therapy (CRT) implantation among patients with mild heart failure (HF). The differential cost …

Aims To assess the cost-effectiveness of cardiac resynchronization therapy (CRT) compared
with optimal medical therapy in patients with New York Heart Association (NYHA) II heart …

Objectives: The analysis goal was to estimate incremental cost-effectiveness ratios (ICERs)
for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure …

Abstract Aims Whilst the CArdiac REsynchronization in Heart Failure (CARE-HF) trial has
shown that cardiac resynchronization therapy (CRT) leads to reduced morbidity and …

Objectives: This study sought to assess the lifelong extrapolated patient outcomes with
cardiac resynchronization therapy (CRT) in mild heart failure (HF), beyond the follow-up of …

Objectives: This article describes the framework of a comprehensive European model
developed to assess clinical and economic outcomes of cardiac resynchronization therapy …

Objectives To assess the clinical effectiveness and cost-effectiveness of cardiac
resynchronisation therapy (CRT) for people with heart failure and evidence of dyssynchrony …

Objective To assess the cost-effectiveness of cardiac resynchronisation therapy (CRT) both
with CRT-P (biventricular pacemaker only) and with CRT-D (biventricular pacemaker with …

Aims Cardiac resynchronization therapy (CRT-P) is an effective treatment for patients with
heart failure and cardiac dyssynchrony with moderate or severe symptoms despite …

BACKGROUND: Cardiac resynchronization therapy (CRT) improves symptoms and survival
in patients with heart failure (HF). However, the devices used to deliver it are costly and can …